About 200 reports

  • 5.2.1 Generic Opioid Usage
  • 2.7.2 Opioid medications
  • Opioid
  • World
  • Market Size
  • Allergan plc
  • Amgen Inc.

Global Non-opioid Pain Patch Market Analysis and Forecasts, By Non-opioid Pain Patch Type ##. ##.

  • Opioid
  • Therapy
  • World
  • Forecast
  • Action
  • 06. Introduction
  • Opioid
  • AstraZeneca PLC
  • Sucampo Pharmaceuticals, Inc.
  • Takeda Pharmaceutical Company Limited
  • Valeant Pharmaceuticals International, Inc.
  • 4.3.1 Opioid Consumption
  • NUMBER OF CHRONIC OPIOID USERS IN GERMANY, 2001-2017
  • Opioid
  • Europe
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Progenics Pharmaceuticals, Inc.

Opioids Market Overview ##. ##.

  • Opioid
  • Asia
  • Europe
  • World
  • Market Size

Opioid Market, by product, 2013 - 2024 (USD Million) TABLE ## U. S.

  • Opioid
  • Pharmaceutical
  • Therapy
  • North America
  • Forecast
  • OPIOID PRESCRIPTIONS
  • ADVANCES IN OPIOID RECEPTOR RESEARCH
  • Opioid
  • United States
  • Actavis plc
  • Bedrocan Canada Inc.
  • Medical Marijuana, Inc.
  • 3.2 Opioid Sales in US Chronic Pain Market - Forecast: Sizing &
  • US Opioid Sales in Chronic Pain Therapy Market - Forecast: 2014F-2019F (US$ B)
  • Opioid
  • United States
  • Egalet Corporation
  • Pfizer Inc.
  • Zogenix, Inc.

Scope Dosage and treatment regimes for major opioids used in pain management - - Which opioids are used for opioid-naïve patients and for patients that experience continuous pain but respond well to opioids?

  • Analgesic
  • Opioid
  • Therapy
  • Germany
  • Japan
  • 3. Opioid Dependence Market
  • 1.5 OPIOIDS OVERVIEW
  • Opioid
  • United States
  • Egalet Corporation
  • Pfizer Inc.
  • Purdue Pharma L.P.

Since the availability of ADF opioids have you become more reluctant to prescribe generic opioids which do not have an ADF?

  • Opioid
  • Pharmaceutical
  • Therapy
  • Opioids
  • Opioids
  • Opioid
  • Market Size
  • BioDelivery Sciences International, Inc.
  • ProStrakan Group plc
  • Teva Pharmaceuticals Ltd.

Opioid drugs in the current market have a space for tamper-resistant formulations.

  • Opioid
  • Therapy
  • United States
  • Demand
  • Market Size

Physician Views: Can Movantik revolutionise the opioid-induced constipation market?

  • Opioid
  • Pharmaceutical
  • Therapy
  • World
  • Demand
  • Opioid-Induced Constipation (OIC) - Product Development Milestones
  • Opioid-Induced Constipation (OIC) - Dormant Projects
  • Gastrointestinal Drug
  • Opioid
  • United States
  • World
  • Product Initiative

Private Label and Others.............. ## Opioids.............. ## Table ##: Market Shares of Leading Opioids Brands Worldwide (2015) - Percentage Share Breakdown by Value for Codeine, Hydrocodone, Oxycodone and Others.............. ## ##.

  • Analgesic
  • Opioid
  • United States
  • Demand
  • Market Shares

IR opioids- Abuse deterrent potential ##.

  • Analgesic
  • Opioid
  • Therapy
  • United States

and Others.............. ## Opioids.............. ## Table ##: Market Shares of Leading Opioids Brands Worldwide (2015) - Percentage Share Breakdown by Value for Codeine, Hydrocodone, Oxycodone and Others.............. ## Bismuth Potassium Citrate.............. ## Table ##: Market

  • Opioid
  • Therapy
  • United States
  • Demand
  • Market Shares
  • Opium (Opioid) Addiction - Therapeutics Assessment
  • Opium (Opioid) Addiction - Drug Profiles
  • Opioid
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • VACCINE FOR OPIOID ADDICTION - DRUG PROFILE
  • Opium (Opioid) Addiction - Therapeutics Assessment
  • Opioid
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) - Product Development Milestones
  • Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) - Dormant Products
  • Analgesic
  • Hospital
  • Hypertension
  • Opioid
  • Therapy
  • Opioid-Induced Constipation (OIC) - Therapeutics Assessment
  • Opioid-Induced Constipation (OIC) - Product Development Milestones
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Opioid
  • United States
  • Product Initiative
  • Latest Clinical Trials News on Opium (Opioid) Addiction
  • Top Companies Participating in Opium (Opioid) Addiction Therapeutics Clinical Trials
  • Clinical Trial
  • Neurology
  • Opioid
  • World
  • Product Initiative
  • TOP COMPANIES PARTICIPATING IN OPIOID-INDUCED CONSTIPATION (OIC) THERAPEUTICS CLINICAL TRIALS
  • Clinical Trials by G7 Countries: Proportion of Opioid-Induced Constipation (OIC) to Toxicology Clinical Trials
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Opioid
  • World
  • Product Initiative
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, Global, Clinical Trials and Average Enrollment by
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Opioid
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) - Overview
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) - Therapeutics Assessment
  • Gastrointestinal Drug
  • Opioid
  • Pharmaceutical
  • Therapy
  • World

Promotional Audit Report The ## Key Questions Addressed by this Report: • How many physicians were reached by Conzip through personal promotion in 2016 and how does this compare to its peer set in the Pain & ###; Opioids markets?

  • Health Care Provider
  • Health Services
  • Opioid
  • Therapy
  • United States

Promotional Audit Report The ## Key Questions Addressed by this Report: • How many physicians were reached by Hysingla ER through personal promotion in 2016 and how does this compare to its peer set in the Pain & ###; Opioids markets?

  • Health Care Provider
  • Hospital
  • Opioid
  • Therapy
  • United States

Promotional Audit Report The ## Key Questions Addressed by this Report: • How many physicians were reached by Fentora through personal promotion in 2016 and how does this compare to its peer set in the Cancer Pain and Pain & ###; Opioids markets?

  • General Medicine And Specialty Medicine
  • Health Care Provider
  • Opioid
  • Therapy
  • United States

Promotional Audit Report The ## Key Questions Addressed by this Report: • How many physicians were reached by Abstral through personal promotion in 2016 and how does this compare to its peer set in the Cancer Pain and Pain & ###; Opioids markets?

  • Health Care Provider
  • Healthcare
  • Opioid
  • Therapy
  • United States